GLYBURIDE AND METFORMIN HYDROCHLORIDE

Post-LOE

glyburide and metformin hydrochloride

Aurobindo Pharma

ANDAORALTABLET

Approved

Nov 2007

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

GLYBURIDE AND METFORMIN HYDROCHLORIDE (glyburide and metformin hydrochloride) by Aurobindo Pharma is pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. Approved for sulfonylurea [epc]. First approved in 2007.

Drug data last refreshed 19h ago

Mechanism of Action

pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. Sulfonylureas bind to the sulfonylurea receptor in the pancreatic beta-cell plasma membrane, leading to closure of the ATP-sensitive potassium channel, thereby stimulating the release of insulin. Metformin is an…

Pharmacologic Class:

Sulfonylurea

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Company

Worked on GLYBURIDE AND METFORMIN HYDROCHLORIDE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.